Hypereosinophilia and Left Ventricular Thrombus: A Case Report and Literature Review

Aleksan Khachatryan1, Hakob Harutyunyan2, Mitchell Psotka3

  • 1Department of Internal Medicine, University of Maryland Medical Center, Midtown Campus, Baltimore, USA.

Cureus
|July 5, 2024
PubMed

Insights

Left ventricular thrombus (LVT) is rare in normal heart function. This case highlights hypereosinophilia (HE) as a potential cause of LVT and thromboembolism, even without confirmed eosinophilic myocarditis.

Area of Science:

  • Cardiology
  • Hematology
  • Internal Medicine

Background:

  • Left ventricular thrombus (LVT) is typically a complication of left ventricular (LV) systolic dysfunction from myocardial infarction.
  • However, LVT can occur in normal LV systolic function, associated with rare conditions like hypereosinophilic syndrome (HES).
  • Hypereosinophilia (HE) is linked to thrombotic events, with intracardiac thrombus being a known complication of eosinophilic myocarditis (EM), a manifestation of HES.

Observation:

  • A 63-year-old male with normal LV systolic function presented with thromboembolic complications.
  • The patient had hypereosinophilia (HE) but a noncontributory hypercoagulability workup.
  • Diagnostic evaluation for EM and Loeffler endocarditis was inconclusive.

Findings:

  • The patient developed left ventricular thrombus (LVT) despite normal LV systolic function.
  • Hypereosinophilia (HE) was present, but specific diagnoses of eosinophilic myocarditis (EM) or Loeffler endomyocarditis were not confirmed.
  • A literature review identified similar rare cases linking HE to LVT.

Implications:

  • This case underscores that LVT with normal LV systolic function can be associated with hypereosinophilia (HE), even without definitive evidence of eosinophilic myocarditis (EM).
  • It highlights the importance of considering HE in the etiological workup of LVT, especially in unexplained thromboembolic events.
  • Further research into the pathophysiology and diagnostic criteria for hypereosinophilic cardiac involvement is warranted to improve patient outcomes.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...